Status:
RECRUITING
Implementation of IVS3 for Upper Limb Motor Recovery
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Dessintey Inc.
Conditions:
Neglect, Hemispatial
Stroke, Cardiovascular
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 dev...
Detailed Description
This study will investigate the implementation of the intensive visual stimulation three (IVS3) device in the outpatient rehabilitation setting. This is a phase I/II open label study that will assess ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- English speaking
- History of ischemic or hemorrhagic stroke ≥ 6 months prior to study enrolment
- FMA-UE: 20 \< x \< 50 (moderate impairments)
- With or without hemi spatial neglect
Exclusion
- Spasticity or increased tone with MAS ≥3 in the upper extremity
- Unable to communicate effectively or provide informed consent
- Significant visual impairments
- Concurrent occupational therapy being received outside of the study
- Pregnant or incarcerated individuals
Key Trial Info
Start Date :
October 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06483230
Start Date
October 2 2024
End Date
June 1 2027
Last Update
October 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106
New York, New York, United States, 10065